David McCullough, VP at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 14,271 shares at $7.02 ($100K) on 2010-01-22, disclosed to the SEC on 2010-01-25.
Scheduled sale ($100k) by VP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BCRX | SELL | 2011-12-08 | $13K | — | Filing → |